The effects of some imidazopyrazine derivatives on telomerase inhibition, mtDNA damage and mtDNA copy number
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2017Yazar
Mutlu, Ayşe GülBilginer, Abdulkerim
Kayağil, İsmail
Yıldız, Hülya
Bayhan, Ülkü
Yılmaz, İnanç
Demirayak, Şeref
Üst veri
Tüm öğe kaydını gösterKünye
Mutlu, A. G., Bilginer, A., Kayağil, İ., Yıldız, H., Bayhan, Ü., Yılmaz, İ. ... Demirayak, Ş. (2017). The effects of some imidazopyrazine derivatives on telomerase inhibition, mtDNA damage and mtDNA copy number. Acta Pharmaceutica Sciencia, 55(3), 31-41. https://dx.doi.org/10.23893/1307-2080.APS.05517Özet
Imidazopyrazine derivatives have been studied for their curative effects on some diseases like cancer and neurological problems; also, some of these molecules have been patented. Primary human cells exhibit limited replicative potential but the cancer cells divided unlimitedly with passage in culture. This immortality is mainly a result of telomerase activity. We investigated the possible telomerase inhibitor effect and possible mtDNA damage action of five imidazopyrazine derivatives. Telomerase activities were measured by the PCR-ELISA based TRAP method and mtDNA damage assays were achieved by quantitative PCR. We used zebrafish as a model organism for our research. In the application of 6-(4-Metylphenyl-8-(4-chlorophenyl)imidazo[1,2-a]pyrazine (C19H14N3Cl), it was determined that this compound inhibit telomerase activities to a statistically significant degree. The obtained results from molecular docking studies also supported the experimental results. Accordingly, this compound has the probability to be used as an anti-cancer agent after detailed studies.
Scopus Q Kategorisi
Q4Kaynak
Acta Pharmaceutica ScienciaCilt
55Sayı
3Koleksiyonlar
- Makale Koleksiyonu [276]
- Scopus İndeksli Yayınlar Koleksiyonu [6360]